greater
identifi
human
pathogen
zoonot
origin
infect
human
mean
anim
reservoir
diseas
includ
ubiquit
virus
like
influenza
less
common
deadli
ill
like
rabi
neglect
parasit
echinococcosi
cysticercosi
subset
bacteri
zoonos
similarli
vari
common
pathogen
industri
set
includ
salmonella
bartonella
hensela
agent
catscratch
diseas
exist
alongsid
diseas
poverti
tropic
like
melioidosi
burkholderia
pseudomallei
leptospirosi
chapter
review
three
key
zoonot
bacteri
diseas
implic
potenti
bioweapon
use
diseas
weapon
long
inglori
histori
earli
fourth
centuri
bce
herodotu
wrote
scythian
archer
dip
arrow
decompos
cadav
human
snake
prior
fire
enemi
intent
use
smallpox
weapon
war
nativ
american
histor
attest
french
indian
war
organ
biowarfar
program
full
knowledg
koch
postul
germ
theori
diseas
began
small
scale
first
world
war
expand
dramat
interwar
year
second
world
war
japanes
imperi
govern
known
releas
pathogen
directli
region
china
nazi
germani
perform
human
experiment
biowarfar
appear
util
combat
follow
war
unit
state
soviet
union
largescal
biowarfar
program
sign
convent
prohibit
develop
product
stockpil
bacteriolog
biolog
toxin
weapon
destruct
bwc
despit
bwc
howev
nation
continu
conduct
research
bioweapon
demonstr
accident
releas
bacillu
anthraci
town
sverdlovsk
russia
recent
year
nonstat
entiti
rogu
individu
cult
terrorist
movement
come
play
larger
role
use
bioterror
notabl
intent
mail
b
anthraci
spore
unit
state
although
three
diseas
anthrax
plagu
tularemia
discuss
consid
potenti
bioweapon
import
recogn
natur
occur
case
diseas
far
common
case
bioterror
inde
anthrax
clearli
use
weapon
terror
war
human
target
modern
time
distinct
chemic
weapon
use
mani
time
mani
set
despit
critic
case
diseas
promptli
report
region
nation
health
author
whenev
suspect
order
safeguard
patient
clinic
staff
bystand
public
health
aerob
gramposit
sporeform
bacterium
occur
natur
soil
mani
region
world
commonli
diseas
herbivor
infect
graze
contamin
soil
anthrax
may
transmit
human
exposur
infect
anim
consumpt
inhal
spore
wool
hide
inocul
skin
recent
inject
contamin
drug
shortli
septemb
terrorist
attack
unit
state
public
fear
stoke
case
anthrax
due
spore
sent
public
figur
mail
result
death
endem
anthrax
remain
import
public
health
threat
develop
countri
well
occasion
diseas
veterinarian
farmer
inject
drug
user
industri
set
b
anthraci
produc
trio
plasmidencod
protein
protect
antigen
edema
factor
lethal
factor
caus
virul
potenti
target
therapi
protect
factor
bind
two
protein
creat
two
toxin
edema
toxin
lethal
toxin
mediat
tissu
injuri
human
edema
toxin
impair
intracellular
water
homeostasi
produc
cellular
edema
lethal
toxin
stimul
highlevel
product
tumor
necrosi
lead
lysi
macrophag
releas
addit
mediat
inflamm
multisystem
organ
failur
death
clinic
manifest
anthrax
present
syndrom
anthrax
vari
depend
rout
exposur
cutan
anthrax
compris
case
result
direct
inocul
b
anthraci
spore
skin
break
inject
follow
germin
soft
tissu
necrosi
black
coallik
eschar
painless
lesion
sourc
anthrax
name
greek
word
coal
frequent
surround
rim
edema
may
surround
eschar
slough
within
week
onset
fever
lymphang
pain
proxim
lymphadenopathi
typic
accompani
lesion
secondari
hematogen
spread
diseas
common
mortal
untreat
case
fig
gastrointestin
oropharyng
anthrax
rare
form
anthrax
report
rural
part
develop
world
includ
subsaharan
africa
well
eastern
southern
central
asia
occur
ingest
contamin
undercook
meat
oropharyng
diseas
mucos
edema
ulcer
follow
develop
pharyng
pseudomembran
potenti
airway
obstruct
gastrointestin
anthrax
highli
lethal
necrosi
develop
throughout
entir
gastrointestin
tract
result
pain
fever
nausea
dysenteri
viscer
perfor
sepsi
oropharyng
form
pseudomembran
seen
oropharynx
upper
airway
obstruct
develop
gastrointestin
form
necrot
infect
progress
esophagu
cecum
fever
nausea
vomit
abdomin
pain
gastrointestin
bleed
bloodi
diarrhea
typic
symptom
death
result
intestin
perfor
sepsi
inhal
anthrax
lethal
form
diseas
result
deposit
anthrax
spore
alveoli
follow
inhal
follow
phagocytosi
pulmonari
macrophag
b
anthraci
transport
via
lymphat
mediastin
lymph
node
period
dormanc
may
last
day
endospor
germin
releas
edema
lethal
toxin
produc
fulmin
often
lethal
ill
typic
clinic
cours
inhal
anthrax
biphas
initi
nonspecif
syndrom
includ
fever
dri
cough
dyspnea
chest
pain
myalgia
may
resembl
typic
viral
respiratori
infect
day
sever
ill
follow
hemorrhag
mediastin
respiratori
failur
shock
mediastin
widen
larg
pleural
effus
common
find
airspac
opac
chest
radiographi
less
frequent
although
hemorrhag
necrot
pneumon
note
autopsi
specimen
clinic
signific
pericardi
effus
ascit
occur
victim
sverdlovsk
outbreak
respect
may
requir
drainag
bacteremia
typic
lead
secondari
mening
half
case
inhal
anthrax
requir
aggress
therapi
fig
diagnosi
anthrax
complex
requir
high
index
suspicion
given
infrequ
diseas
industri
countri
typic
laboratori
find
includ
neutrophilpredomin
leukocytosi
normal
rang
cell
per
elev
liver
transaminas
hyponatremia
hypoxemia
chest
radiographi
demonstr
mediastin
widen
pleural
effus
consolid
infiltr
less
frequent
mediastin
widen
particular
strongli
suggest
anthrax
appropri
clinic
syndrom
mandat
consider
diagnosi
close
coordin
hospit
microbiolog
laboratori
well
public
health
laboratori
critic
diagnosi
anthrax
larg
gramposit
rod
short
chain
posit
india
ink
stain
presumpt
b
anthraci
confirmatori
test
obtain
special
cultur
method
gener
necessari
b
anthraci
grow
readili
clinic
specimen
convent
media
routin
biosafeti
level
condit
biosafeti
cabinet
adequ
staff
safeti
gener
hospit
laboratori
fulli
character
suspect
anthrax
specimen
confirmatori
test
perform
public
health
laboratori
via
center
diseas
control
prevent
cdc
laboratori
respons
network
unit
state
public
health
england
health
protect
scotland
unit
kingdom
compar
nation
agenc
unit
state
advanc
anthrax
diagnost
avail
cdc
us
armi
medic
research
institut
infecti
diseas
usamriid
naval
medic
research
center
nmrc
includ
serolog
test
immunohistochemistri
polymeras
chain
reaction
pcr
recommend
clinic
specimen
analysi
vari
present
syndrom
includ
blood
cultur
serum
antibodi
test
plasma
direct
detect
lethal
factor
seros
fluid
cerebrospin
fluid
tissu
biopsi
cutan
eschar
complet
guid
syndrom
avail
cdc
websit
http
wwwcdcgovanthraxspecificgroupslabprofessionalsrecommendedspecimenhtml
treatment
anthrax
also
vari
base
clinic
syndrom
divid
mening
nonmening
diseas
purpos
antimicrobi
therapi
given
increas
sever
intens
therapi
anthrax
mening
recommend
patient
receiv
either
confirm
diagnosi
via
earli
lumbar
punctur
empir
therapi
direct
mening
import
recogn
mortal
inhal
anthrax
without
mening
carri
except
high
mortal
even
appropri
therapi
despit
gener
critic
care
principl
respiratori
hemodynam
organ
systembas
support
still
appli
empir
antimicrobi
manag
anthrax
includ
intraven
fluoroquinolon
ciprofloxacin
levofloxacin
moxifloxacin
carbapenem
meropenem
imipenem
either
protein
synthesi
inhibitor
rifampin
either
clindamycin
linezolid
accept
protein
synthesi
inhibitor
rifampin
indirectli
block
protein
synthesi
inhibit
rna
polymeras
thu
messeng
rna
synthesi
appear
compar
efficaci
nonmening
diseas
may
treat
either
fluoroquinolon
carbapenem
combin
protein
synthesi
inhibitor
antimicrobi
suscept
determin
intraven
penicillin
g
ampicillin
may
use
lieu
carbapenem
suscept
isol
see
tabl
given
high
risk
matern
fetal
death
anthrax
infect
pregnant
women
receiv
therapi
nonpregn
adult
uncompl
cutan
anthrax
treat
oral
ciprofloxacin
doxycyclin
day
sinc
concomit
inhal
exposur
difficult
exclud
howev
extend
cours
day
therapi
usual
prefer
addit
antimicrobi
drug
therapi
routin
intens
care
support
measur
provid
critic
ill
patient
anthrax
periton
effus
ascit
may
serv
reservoir
lethal
toxin
seros
drainag
associ
surviv
retrospect
case
hemodynam
support
vasopressor
may
provid
per
standard
practic
patient
shock
although
limit
data
use
adjunct
corticosteroid
interest
note
lethal
toxin
appear
repress
glucocorticoid
receptor
corticosteroid
may
util
treatment
anthraxassoci
airway
edema
addit
vasopressorresist
shock
combin
antibiot
indic
corticosteroid
immunotherapi
avail
given
combin
antibacteri
therapi
raxibacumab
obiltoxaximab
two
distinct
monoclon
antibodi
direct
protect
antigen
anthrax
immunoglobulin
intraven
aigiv
purifi
polyclon
prepar
antianthrax
immunoglobulin
deriv
vaccin
donor
three
either
approv
orphan
drug
statu
unit
state
european
union
none
commerci
avail
must
obtain
cdc
strateg
nation
stockpil
absenc
compar
human
trial
three
reason
option
administ
suspect
confirm
anthrax
victim
prophylaxi
patient
expos
anthrax
includ
either
oral
ciprofloxacin
mg
twice
daili
levofloxacin
mg
daili
doxycyclin
mg
twice
daili
day
regardless
laboratori
test
result
nasal
swab
test
cultur
pcr
confirm
exposur
anthrax
larg
group
neg
swab
exclud
exposur
individu
person
expos
penicillinsuscept
strain
may
receiv
prophylaxi
highdos
oral
penicillin
amoxicillin
limit
circumst
fluoroquinolon
doxycyclin
prefer
anthrax
vaccin
avabiothrax
bioport
corpor
lans
michigan
usa
licens
human
anthrax
vaccin
unit
state
receiv
licensur
itali
germani
unit
kingdom
franc
netherland
poland
singapor
vaccin
deriv
supernat
materi
cultur
toxigen
nonencapsul
strain
b
anthraci
approxim
individu
seroconvert
third
dose
vaccin
us
militari
current
use
sixdos
seri
headach
system
symptom
report
us
militari
recipi
inject
site
reaction
plagu
caus
gramneg
bacillu
rel
common
pathogen
includ
escherichia
coli
klebsiella
pesti
often
transmit
human
rodent
rabbit
reservoir
via
flea
vector
princip
speci
xenopsylla
cheopi
worldwid
oropsylla
montana
north
america
potenti
rout
transmiss
includ
direct
contact
infect
bodi
fluid
inhal
infect
respiratori
droplet
similar
gramneg
infect
lipopolysaccharid
lp
endotoxin
associ
outer
cell
membran
major
drive
virul
implic
system
inflammatori
respons
acut
respiratori
distress
syndrom
multiorgan
failur
associ
fatal
plagu
malaria
possibl
modern
human
immunodefici
viru
hiv
epidem
infect
profound
effect
human
histori
plagu
justinian
plagu
sixth
centuri
ce
took
live
estim
million
peopl
includ
roman
emperor
betterknown
black
death
fourteenth
centuri
ce
respons
million
death
third
popul
europ
modern
time
outbreak
plagu
struck
china
late
nineteenth
centuri
vietnam
contemporari
plagu
remain
endem
subsaharan
africa
madagascar
current
case
occur
madagascar
alon
suspect
case
new
outbreak
lead
addit
case
death
like
anthrax
cdc
classifi
plagu
categori
threat
agent
potenti
bioweapon
aerosol
releas
kg
yersinia
pesti
popul
five
million
peopl
estim
capabl
caus
infect
death
intent
dispers
yersinia
pesti
aerosol
lead
outbreak
pneumon
plagu
releas
infect
flea
typic
result
bubon
septicem
plagu
outbreak
histor
plagu
describ
bioweapon
tartar
besieg
citi
kaffa
catapult
corps
plagu
victim
citi
plagu
use
bioweapon
militari
forc
russia
sweden
japan
china
biowarfar
program
unit
state
plagu
arsen
destruct
us
biolog
weapon
stockpil
earli
clinic
manifest
plagu
vari
depend
rout
exposur
similar
anthrax
plagu
exist
primarili
cutan
lymphat
form
bubon
plagu
respiratori
form
mode
plagu
complic
third
system
form
incub
period
clinic
manifest
vari
accord
mode
transmiss
eightyf
percent
plagu
case
diagnos
unit
state
bubon
primari
septicem
roughli
primari
pneumon
plagu
bubon
plagu
may
progress
septicem
pneumon
plagu
case
respect
data
plagu
pregnanc
limit
less
common
form
plagu
pharyng
plagu
plagu
mening
occur
less
frequent
bubon
plagu
common
form
natur
occur
plagu
enter
bodi
fleabit
bacteria
migrat
via
cutan
lymphat
region
lymph
node
evad
host
defens
pesti
replic
within
lymph
node
result
lymphaden
produc
signatur
lesion
known
bubo
bubo
develop
groin
axilla
neck
enlarg
lymph
node
necrot
contain
dens
concentr
bacteria
endotoxin
virul
factor
subsequ
contribut
diseas
progress
bacteremia
sepsi
often
death
patient
suspect
bubon
plagu
manag
strict
contact
precaut
includ
use
gown
glove
surgic
mask
clinic
staff
fig
plagu
highli
contagi
airborn
rout
inhal
aerosol
droplet
pesti
infect
host
includ
particl
drain
bubo
result
primari
rapidli
progress
pneumonia
sepsi
rapidli
fatal
without
prompt
treatment
secondari
pneumon
plagu
may
occur
individu
bubon
primari
septicem
plagu
follow
hematogen
spread
pesti
lung
day
incub
rapid
onset
fever
dyspnea
chest
pain
product
cough
acut
hypoxem
respiratori
failur
common
often
requir
mechan
ventil
bilater
alveolar
opac
pleural
effus
occasion
cavit
common
featur
chest
radiographi
secondari
pneumon
plagu
may
nodular
miliari
appear
associ
hematogen
spread
hilar
node
enlarg
often
present
high
risk
transmiss
strict
use
droplet
precaut
clinic
staff
mandatori
addit
gown
glove
use
effect
antimicrobi
therapi
receiv
patient
least
hour
chemoprophylaxi
given
potenti
expos
personnel
although
respir
strictli
necessari
protect
plagu
highconsequ
pathogen
present
fulmin
respiratori
diseas
requir
protect
given
rariti
plagu
set
strong
consider
respir
use
made
initi
phase
evalu
suspect
plagu
untreat
mortal
rate
primari
pneumon
plagu
fig
primari
septicem
plagu
result
direct
inocul
pesti
bacilli
bloodstream
present
febril
sepsi
syndrom
similar
gramneg
bacteremia
delirium
hypotens
nausea
secondari
septicem
plagu
occur
result
progress
either
bubon
pneumon
infect
result
bacteremia
mening
infrequ
occur
hematogen
spread
abdomin
pain
hepatosplenomegali
dissemin
intravascular
coagul
digit
gangren
purpura
fulminan
common
featur
similar
pneumon
plagu
untreat
mortal
rate
septicem
plagu
high
mortal
even
rapid
critic
care
intervent
laboratori
diagnosi
plagu
base
gener
hematolog
chemic
paramet
cultur
serolog
molecular
assay
leukocytosi
neutrophil
predomin
band
form
typic
coagulopathi
increas
level
liver
transaminas
elev
creatinin
occur
sever
ill
gram
stain
lymph
node
aspir
sputum
blood
may
demonstr
gramneg
bacilli
bipolar
stain
similar
enterobacteriacea
cultur
may
posit
pesti
within
hour
although
autom
bacteri
identif
system
may
misidentifi
pesti
newer
mass
spectrometri
system
base
matrixassist
laser
desorptionion
time
flight
malditof
identifi
pesti
rapidli
reliabl
follow
cultur
growth
addit
test
detect
confirm
includ
detect
pesti
antigen
igm
immunoassay
pcr
immunohistochemistri
formalinfix
tissu
test
often
avail
region
nation
refer
laboratori
cdc
laboratori
respons
network
unit
state
emerg
vectorborn
diseas
programm
european
union
plagu
suspect
person
fever
lymphadenopathi
resid
recent
travel
plagueendem
area
bipolarstain
gramneg
bacilli
seen
affect
tissu
diagnosi
plagu
presum
immunofluoresc
stain
smear
materi
posit
presenc
pesti
antigen
singl
serum
specimen
show
level
antibodi
antigen
titer
greater
confirm
plagu
may
base
singl
antibodi
titer
dilut
fourfold
rise
pair
antibodi
titer
multipl
case
pneumon
plagu
nonendem
area
rais
concern
bioterror
treatment
suspect
plagu
delay
await
diagnost
confirm
although
preantibiot
cultur
specimen
obtain
best
possibl
recommend
antimicrobi
drug
treatment
plagu
streptomycin
commonli
gentamicin
current
us
recommend
list
tabl
doxycyclin
shown
efficaci
compar
gentamicin
small
random
trial
patient
princip
bubon
plagu
fluoroquinolon
chloramphenicol
altern
agent
accept
efficaci
methylprednisolon
imipenem
shown
evid
efficaci
murin
model
plagu
lack
support
human
data
time
treatment
last
day
oral
therapi
may
initi
patient
demonstr
clinic
stabil
improv
intent
releas
plagu
exposur
larg
number
patient
presum
respiratori
rout
may
requir
altern
approach
therapi
symptomat
patient
ideal
receiv
treatment
parenter
aminoglycosid
describ
oral
ciprofloxacin
taken
mg
twice
daili
doxycyclin
mg
twice
daili
appropri
option
treatment
postexposur
prophylaxi
includ
person
come
within
meter
infect
patient
pneumon
plagu
addit
appropri
postexposur
prophylaxi
prevent
plagu
reli
care
infect
prevent
practic
present
commerci
avail
vaccin
plagu
patient
suspect
plagu
place
immedi
droplet
precaut
access
patient
room
restrict
essenti
staff
gown
glove
surgic
mask
eye
protect
worn
staff
aerosol
procedur
kept
absolut
minimum
avoid
possibl
note
neg
pressur
isol
mask
necessari
plagu
although
infect
may
present
similarli
pneumon
plagu
eg
sever
coronaviru
infect
sar
mer
may
requir
neg
pressur
room
papr
thu
requir
higher
level
protect
diagnost
test
underway
follow
hour
therapi
appropri
antibiot
clear
clinic
improv
patient
nonpneumon
plagu
pneumon
plagu
may
remov
isol
tabl
tularemia
caus
intracellular
aerob
gramneg
coccobacillu
similar
plagu
natur
smallmamm
reservoir
rabbit
rodent
also
similar
plagu
anthrax
tularemia
occur
primarili
respiratori
form
pneumon
tularemia
primarili
cutan
lymphat
form
ulceroglandular
tularemia
unit
state
former
soviet
union
develop
biolog
weapon
could
dispers
f
tularensi
midtwentieth
centuri
remain
concern
f
tularensi
could
use
agent
bioterror
f
tularensi
surviv
soil
water
anim
carcass
mani
week
chlorin
water
prevent
spread
water
contamin
ten
organ
may
suffici
caus
human
diseas
human
transmiss
often
result
tick
flea
bite
anim
handl
ingest
contamin
food
water
inhal
aerosol
unlik
plagu
direct
humantohuman
transmiss
deliber
aerosol
dispers
f
tularensi
hypothes
caus
largescal
outbreak
sever
respiratori
diseas
tularemia
endem
throughout
northern
hemispher
approxim
case
per
year
occur
unit
state
highest
incid
southcentr
western
state
predomin
mode
transmiss
human
unit
state
tick
bite
often
spring
summer
hunt
similar
outdoor
activ
associ
increas
risk
exposur
europ
incid
tularemia
consider
higher
case
per
year
hungari
czech
republ
case
per
year
sweden
finland
mosquitoborn
transmiss
consumpt
contamin
water
predomin
mode
exposur
part
europ
although
vari
countri
f
tularensi
infect
human
via
conjunctiva
respiratori
tract
gut
break
skin
organ
taken
replic
within
macrophag
lead
apoptosi
macrophag
releas
local
lymph
node
well
bacteremia
bacteremia
lead
secondari
seed
lung
pleura
spleen
liver
kidney
patholog
examin
infect
tissu
may
show
granulomat
inflamm
necrosi
follow
inhal
exposur
hemorrhag
airway
inflamm
may
progress
pneumonia
pleuriti
pleural
effus
human
immun
princip
cellmedi
antibodi
respons
play
role
diagnosi
uncertain
contribut
host
defens
clinic
manifest
tularemia
depend
site
entri
exposur
dose
host
immun
factor
base
site
initi
infect
present
syndrom
tularemia
may
describ
primari
pneumon
typhoid
ulceroglandular
oculoglandular
oropharyng
septic
ulceroglandular
tularemia
common
form
infect
typic
follow
week
vector
bite
anim
contact
major
patient
present
fever
chill
headach
cough
myalgia
occur
mani
nonspecif
constitut
symptom
occur
variabl
frequenc
chest
abdomin
pain
nausea
vomit
diarrhea
hallmark
lesion
tender
papul
site
initi
inocul
subsequ
ulcer
pain
enlarg
lymphadenopathi
proxim
ulcer
lesion
may
clinic
resembl
plagu
bubo
plagu
must
consid
differenti
diagnosi
pure
glandular
form
lymphadenopathi
visibl
ulcer
occur
well
case
ingest
contamin
materi
exud
pharyng
tonsil
may
develop
subsequ
pharyng
ulcer
cervic
lymphadenopathi
inocul
eye
lead
oculoglandular
tularemia
also
accompani
cervic
lymphadenopathi
case
system
tularemia
without
clinic
appar
lymphadenopathi
known
typhoid
tularemia
fever
diarrhea
shock
mening
sign
typic
fig
result
inhal
aerosol
organ
hematogen
spread
site
infect
follow
inhal
organ
patient
may
suffer
initi
nonspecif
fever
chill
follow
dri
minim
product
cough
pleurisi
dyspnea
subsequ
hemoptysi
respiratori
symptom
absent
nearli
half
patient
recent
seri
finland
howev
pleural
effus
common
may
unilater
bilater
pneumon
tularemia
progress
rapidli
acut
hypoxem
respiratori
failur
dissemin
intravascular
coagul
rhabdomyolysi
eventu
multiorgan
failur
virtual
organ
may
involv
sever
tularemia
includ
periton
pericard
append
osteomyel
mening
although
present
less
frequent
classic
form
mortal
rate
untreat
pneumon
tularemia
rapid
institut
antimicrobi
therapi
reduc
moral
rate
less
diagnosi
tularemia
often
delay
due
nonspecif
present
sign
symptom
case
pneumon
typhoid
diseas
may
confound
clinic
similar
plagu
anthrax
case
ulceroglandular
diseas
delay
absent
respons
routin
treatment
skin
ulcer
communityacquir
pneumonia
may
serv
diagnost
clue
may
histori
anim
arthropod
outdoor
freshwat
exposur
routin
laboratori
test
usual
lack
distinguish
featur
may
includ
mild
lymphocytosi
elev
liver
transaminas
marker
rhabdomyolysi
elev
serum
creatin
kinas
concentr
urin
myoglobin
chest
radiograph
often
show
unilater
bilater
airspac
opac
hilar
adenopathi
pleural
effus
approxim
cavit
occur
approxim
case
chest
radiograph
may
normal
patient
although
comput
tomographi
reveal
thorac
patholog
great
major
although
f
tularensi
may
cultiv
blood
tissu
sputum
clinic
microbiolog
laboratori
requir
special
media
usual
cysteineenrich
grow
special
precaut
must
taken
protect
laboratori
staff
similar
plagu
anthrax
like
pathogen
interest
clinician
must
notifi
microbiolog
laboratori
event
suspect
case
routin
microbiolog
procedur
perform
biosafeti
level
condit
biolog
safeti
cabinet
aerosol
procedur
must
occur
biosafeti
level
condit
serolog
diagnosi
may
util
given
challeng
involv
cultur
francisella
serum
test
enzymelink
immunosorb
assay
elisa
may
neg
earli
ill
typic
produc
fourfold
rise
titer
cours
diseas
singl
antif
tularensi
igg
titer
suffici
support
diagnosi
howev
elisa
detect
antibodi
bacteri
endotoxin
falseposit
test
may
aris
case
infect
bacteria
structur
similar
endotoxin
includ
brucella
proteu
yersinia
speci
confirmatori
test
western
blot
immunofluoresc
microagglutin
titer
test
improv
specif
elisa
test
antigen
detect
method
direct
fluoresc
antibodi
immunochem
stain
may
perform
tissu
specimen
along
pcrbase
test
may
valuabl
outbreak
set
standard
treatment
tularemia
adult
streptomycin
mg
per
kg
given
intramuscularli
im
intraven
iv
twice
daili
gentamicin
mg
per
kg
given
im
iv
daili
equival
efficaci
standard
therapi
nowaday
milder
case
ulceroglandular
diseas
may
treat
doxycyclin
iv
oral
fluoroquinolon
chloramphenicol
may
given
select
case
avail
betalactam
macrolid
recommend
treatment
streptomycin
gentamicin
ciprofloxacin
continu
day
treatment
doxycyclin
chloramphenicol
continu
day
patient
begin
treatment
doxycyclin
chloramphenicol
ciprofloxacin
switch
oral
antibiot
clinic
improv
toler
oral
medic
complet
medic
recommend
may
seen
tabl
chemoprophylact
regimen
prevent
tularemia
similar
use
plagu
individu
expos
f
tularensi
may
protect
system
infect
receiv
prophylact
antibiot
incub
period
postexposur
prophylaxi
either
doxycyclin
ciprofloxacin
taken
oral
twice
daili
day
recommend
regimen
ciprofloxacin
gener
prefer
doxycyclin
pregnanc
either
accept
given
risk
seriou
diseas
low
risk
skelet
abnorm
fetu
rel
brief
tetracyclin
exposur
live
attenu
vaccin
first
develop
russia
gener
avail
given
unit
state
us
armi
medic
research
institut
infecti
diseas
usamriid
investig
new
drug
vaccin
administ
via
scarif
similar
smallpox
vaccin
due
dwindl
stock
origin
vaccin
strain
newer
attenu
strain
test
recent
phase
trial
novel
vaccin
show
high
rate
seroconvers
among
recipi
author
us
militari
servic
member
work
prepar
part
offici
duti
titl
usc
provid
copyright
protect
titl
avail
work
unit
state
govern
titl
usc
defin
us
govern
work
work
prepar
militari
servic
member
employe
us
govern
part
person
offici
duti
view
express
articl
author
necessarili
reflect
offici
polici
posit
depart
navi
depart
defens
us
govern
